IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 24 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $442,825 | -45.9% | 241,981 | -12.5% | 0.00% | – |
| Q2 2023 | $818,982 | -22.5% | 276,683 | -27.5% | 0.00% | – |
| Q1 2023 | $1,057,071 | -39.1% | 381,614 | +16.4% | 0.00% | – |
| Q4 2022 | $1,736,916 | +33.6% | 327,720 | +0.6% | 0.00% | – |
| Q3 2022 | $1,300,000 | -14.7% | 325,661 | -17.5% | 0.00% | – |
| Q2 2022 | $1,524,000 | -7.0% | 394,662 | +23.9% | 0.00% | – |
| Q1 2022 | $1,638,000 | +72.2% | 318,500 | +79.6% | 0.00% | – |
| Q4 2021 | $951,000 | -11.9% | 177,366 | +2.1% | 0.00% | – |
| Q3 2021 | $1,080,000 | +1061.3% | 173,703 | +1027.9% | 0.00% | – |
| Q2 2021 | $93,000 | – | 15,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 1,058,035 | $2,931 | 0.15% |
| Gradient Capital Advisors, LLC | 26,808 | $74,258 | 0.03% |
| WEST PACES ADVISORS INC. | 1,665 | $4,612 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 28,652 | $79,366 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,484 | $48,430 | 0.00% |
| CITIGROUP INC | 7 | $19 | 0.00% |
| MORGAN STANLEY | 533 | $1,476 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 2,255 | $6,251 | 0.00% |
| WOLVERINE TRADING, LLC | 11,700 | $33 | 0.00% |